Gastro Broadcast

Gastro Broadcast
  • 5.0 (4)
  • MEDICINE
  • UPDATED MONTHLY
Gastro Broadcast

Independent GI physicians and administrative leaders discuss issues that impact gastroenterology.

  1. DEC 17

    Episode #69: Understanding the Financial Burden of IBD | Kevin Harlen & Laura Wingate | Crohn’s & Colitis Foundation

    Kevin Harlen interviews Laura Wingate, chief education, support, and advocacy officer with the Crohn's & Colitis Foundation about a recent survey which shows that more than 40 percent of patients with inflammatory bowel disease (IBD) have made significant financial trade-offs to afford their healthcare. The survey, published in Inflammatory Bowel Diseases, included responses from more than 2,200 IBD patients and caregivers, who highlighted persistent challenges. Among respondents, 30 percent reported giving up vacations or major household purchases, 22 percent increased their credit card debt, and 21 percent cut back on essential items such as food, clothing, or basic household items. Join Kevin and Laura as they explore what can done to ensure that IBD patients can access the medications they need without undue financial hardship. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 69, presented by TissueCypher from Castle Biosciences

    17 min

  2. NOV 26

    Episode #68: Insights on GLP-1 Medications and Endoscopy Prep | Fred Rosenberg & Ruchi Mathur | Cedars-Sinai

    Dr. Fred Rosenberg interviews Dr. Ruchi Mathur, director of the Diabetes Program in the Division of Endocrinology, Diabetes and Metabolism and an endocrinologist at the Weight Loss Center, at Cedars-Sinai. Cedars-Sinai recently released a study which found that patients who take a class of widely prescribed medications (GLP-1) to manage diabetes and obesity may require extra preparations before undergoing upper endoscopy procedures. Join Dr. Rosenberg and Dr. Mathur as they explore how gastroenterologists can advise patients who take GLP-1 medications when preparing for endoscopic procedures, to have the best results. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 68

    20 min

  3. NOV 13

    Episode #67: Understanding Nutritional Strategies for IBD | Naresh Gunaratnam, Kim Beall & Ashwin Ananthakrishnan

    Dr. Naresh Gunaratnam interviews Kim Beall, co-founder and managing director of Nutritional Therapy for IBD and Dr. Ashwin Ananthakrishnan, who is the Director of the Massachusetts General Hospital Crohn's and Colitis Center about their work to advance evidence-based nutrition as part of IBD treatment plans. When nutritional strategies are used in combination with medications, additional pathways are engaged to improve symptoms, quality of life and aid tissue healing. When patients are able to access evidence-based nutritional therapy under the guidance of a healthcare providers it can them find foods to restore a healthy relationship with food and work their way back to a well-balanced diet of healthy, foods while at the same time feeling well again. Join Dr. Gunaratnam, Ms. Beall and Dr. Ananthakrishnan as they explore how Nutritional Therapy for IBD works to inform, support, and empower patients and clinicians by providing education and essential tools and resources to utilize nutritional therapy alongside medication. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 67, presented by TissueCypher from Castle Biosciences

    30 min

  4. OCT 23

    Episode #66: This Colonoscopy Prep Includes Chocolate Chip Cookies |Lisa Mathew & Jeff Scott | Happy Colon Foods

    Dr. Lisa Mathew interviews Dr. Jeff Scott, a gastroenterologist and founder of Happy Colon Foods, a company that prepares meal kits that are compliant with the diet requirements before a colorectal screening. Happy Colon Foods is designed to mimic a typical day, with three meals and snacks in between, including mac n' cheese and cookies. Because smaller doses of laxatives are spread throughout the day, many patients can work either part or most of their prep day. A large, randomized trial published in 2013 compared the results of clear-liquid only and low-residue diets, and found that a low-residue diet, is just as effective than a diet restricted to clear liquids. Join Dr. Mathew and Dr. Scott as they explore how this type of colonoscopy prep can remove some of the difficulty of preparing for a colonoscopy and encourage people to get screened. - Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 66, presented by TissueCypher from Castle Biosciences

    26 min

  5. OCT 9

    Episode #65: Identifying High-Risk Barrett’s Esophagus Patients | Lisa Mathew & Raman Muthusamy | UCLA School of Medicine

    Dr. Lisa Mathew interviews Dr. Raman Muthusamy, professor of clinical medicine at the David Geffen School of Medicine at UCLA, and medical director of endoscopy for UCLA Health, about a new clinical guideline for endoscopic eradication therapy to prevent the progression of Barrett’s esophagus to esophageal cancer. Esophageal cancer is preventable if high-risk patients, such as those with Barrett’s Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett’s tissue. Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate. Join Dr. Mathew and Dr. Muthusamy as they explore new technologies for identifying patients who are most at risk and the potential innovations that could stop a majority of Barrett’s Esophagus patients from progressing to esophageal cancer. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 65, presented by TissueCypher from Castle Biosciences

    17 min

  6. SEP 24

    Episode #64: Pros & Cons of New Blood Test for Colorectal Cancer | Fred Rosenberg & Lauren Bleich | Gastro Health

    Dr. Fred Rosenberg interviews Dr. Lauren Bleich, of Gastro Health, who serves as president of the Massachusetts Gastroenterology Society about a new blood-based screening test from Guardant Health for colorectal cancer. This summer, a U.S. Food & Drug Administration advisory panel voted that the Shield test was safe and effective, after reviewing evidence from a study which showed that the test correctly detected colorectal cancer in 83% of people confirmed to have it. However, the panel cautioned that while the test is effective in finding later-stage cancers, it only detected 13% of earlier-stage polyps. Join Dr. Rosenberg and Dr. Bleich as they discuss the opportunities and limitations of this new test in detecting polyps, and why colonoscopy remains the gold standard for colorectal cancer screening, as the only test that prevents colon cancer by removing polyps before they can turn into cancer. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 64, presented by TissueCypher from Castle Biosciences

  7. SEP 10

    Episode #63: Despite ACA Mandate Most Patients Pay for Bowel Prep | Michael Weinstein & Eric Shah | University of Michigan

    Dr. Michael Weinstein interviews Dr. Eric Shah, director of the Michigan Medicine GI Physiology Laboratories about a study showing that despite a federal law that says bowel preparations needed for colonoscopy should be covered by insurance, many patients are still paying out of pocket. The study, from the University of Michigan Health, analyzed nearly 2.6 million insurance claims from both commercial insurance plans and Medicare Part D, and looked at how many patients paid for bowel prep medications needed for colonoscopy. The Affordable Care Act (ACA) requires that certain preventative services, including colorectal cancer screening, must be covered by insurance plans without cost-sharing for patients. Unfortunately, prescription bowel prep for screening colonoscopy is still subject to cost sharing for most patients, running contrary to the ACA's mandate. When considering that nearly half of patients are cost-shifted toward the use of non-FDA approved over-the-counter regimens, the data suggest that only 17 percent of patients pay zero for their bowel preparation for screening colonoscopy. Of the prescription claims analyzed, only 36 percent had no out-of-pocket costs. Additionally, high-volume preps were more likely to be free compared to new, low-volume or tablet preparations. However, when patients did pay, high-volume preps cost a median of $10, while low-volume preps cost $60. For Medicare Part D, only 25 percent of high-volume preps were free, compared to 10 percent for low-volume preps. Join Dr. Weinstein and Dr. Eric Shah as they discuss how these co-pays for bowel prep can impact patients and what private practice gastroenterologists can do to educate their communities and to engage in advocacy so that co-pays do not present a barrier to colorectal cancer screening. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 63, presented by TissueCypher from Castle Biosciences

    20 min

  8. JUL 10

    Episode #62: Data-Driven Solutions to Improve Healthcare Delivery | Lisa Mathew & Mitesh Rao | OMNY Health

    Dr. Lisa Mathew interviews Dr. Mitesh Rao, chief executive officer of OMNY Health, about the organization's work to connect the healthcare ecosystem through data and insights to transform healthcare delivery, improve clinical outcomes, and address patients’ unmet needs.  OMNY Health recently announced a partnership with several of the nation's leading GI practices to enable insights on patient population characteristics, care delivery patterns, and treatment outcomes based on data extracted from de-identified electronic health records (EHRs). The partnership will provide valuable information on disease severity, rationale behind treatment decisions, treatment efficacy, and impact of social determinants on treatment selection and disease progression. Listen to Dr. Mathew and Dr. Rao as they explore how independent GI practices can be connected with research and development efforts underway in gastroenterology, including Crohn's & Colitis, celiac disease, short bowel syndrome, and many others. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 62, presented by TissueCypher from Castle Biosciences

    24 min
See All (69)

Ratings & Reviews

5
out of 5
4 Ratings

About

Independent GI physicians and administrative leaders discuss issues that impact gastroenterology.

Information

  • Creator
    Gastro Broadcast
  • Years Active
    2021 - 2024
  • Episodes
    69
  • Rating
    Clean
  • Copyright
    © The entire content and design of Gastro Broadcast are the property of Steadfast Collaborative, LLC and are protected under United States and international copyright and trademark laws.
  • Show Website
    Gastro Broadcast

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada